Sernova Corp (SEOVF)
0.2462
-0.01
(-5.10%)
USD |
OTCM |
Jun 14, 16:00
Sernova Price to Book Value: 26.11 for June 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 26.11 |
| June 13, 2024 | 27.51 |
| June 12, 2024 | 22.60 |
| June 11, 2024 | 21.20 |
| June 10, 2024 | 23.79 |
| June 07, 2024 | 24.43 |
| June 06, 2024 | 28.68 |
| June 05, 2024 | 29.41 |
| June 04, 2024 | 29.88 |
| June 03, 2024 | 30.23 |
| May 31, 2024 | 28.25 |
| May 30, 2024 | 23.92 |
| May 29, 2024 | 23.92 |
| May 28, 2024 | 25.46 |
| May 24, 2024 | 24.40 |
| May 23, 2024 | 22.33 |
| May 22, 2024 | 23.05 |
| May 21, 2024 | 22.87 |
| May 20, 2024 | 25.05 |
| May 17, 2024 | 24.93 |
| May 16, 2024 | 25.90 |
| May 15, 2024 | 27.08 |
| May 14, 2024 | 24.82 |
| May 13, 2024 | 27.28 |
| May 10, 2024 | 28.26 |
| Date | Value |
|---|---|
| May 09, 2024 | 29.74 |
| May 08, 2024 | 29.74 |
| May 07, 2024 | 30.52 |
| May 06, 2024 | 29.69 |
| May 03, 2024 | 29.70 |
| May 02, 2024 | 31.61 |
| May 01, 2024 | 31.01 |
| April 30, 2024 | 32.71 |
| April 29, 2024 | 34.91 |
| April 26, 2024 | 33.78 |
| April 25, 2024 | 32.83 |
| April 24, 2024 | 33.71 |
| April 23, 2024 | 34.49 |
| April 22, 2024 | 35.04 |
| April 19, 2024 | 34.89 |
| April 18, 2024 | 34.95 |
| April 17, 2024 | 34.83 |
| April 16, 2024 | 36.32 |
| April 15, 2024 | 36.09 |
| April 12, 2024 | 35.53 |
| April 11, 2024 | 40.31 |
| April 10, 2024 | 30.50 |
| April 09, 2024 | 30.87 |
| April 08, 2024 | 37.06 |
| April 05, 2024 | 38.70 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.684
Minimum
Dec 15 2022
97.73
Maximum
Jan 19 2021
17.82
Average
13.29
Median
Nov 06 2020
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.4687 |
| Aurinia Pharmaceuticals Inc | 2.138 |
| Edesa Biotech Inc | 3.309 |
| Lexaria Bioscience Corp | 6.106 |
| InMed Pharmaceuticals Inc | 0.1706 |
Price to Book Value Related Metrics
| Price | 0.2462 |
| Earnings Yield | -39.10% |
| Market Cap | 74.68M |